Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Change in Acquisitions & Divestments (2022 - 2026)

Zentalis Pharmaceuticals has reported Change in Acquisitions & Divestments over the past 5 years, most recently at $60.0 million for Q1 2026.

  • For Q1 2026, Change in Acquisitions & Divestments changed 0.0% year-over-year to $60.0 million; the TTM value through Mar 2026 reached $250.0 million, down 3.66%, while the annual FY2025 figure was $250.0 million, 7.82% down from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 was $60.0 million at Zentalis Pharmaceuticals, down from $232.1 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $232.1 million in Q4 2025 and troughed at -$307.3 million in Q4 2022.
  • A 5-year average of $63.9 million and a median of $71.5 million in 2024 define the central range for Change in Acquisitions & Divestments.
  • Biggest five-year swings in Change in Acquisitions & Divestments: soared 251.25% in 2023 and later plummeted 251.55% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at -$307.3 million in 2022, then surged by 117.61% to $54.1 million in 2023, then soared by 32.16% to $71.5 million in 2024, then skyrocketed by 224.68% to $232.1 million in 2025, then crashed by 74.15% to $60.0 million in 2026.
  • Business Quant data shows Change in Acquisitions & Divestments for ZNTL at $60.0 million in Q1 2026, $232.1 million in Q4 2025, and -$112.1 million in Q3 2025.